ArticleOral and maxillofacial surgery2026
Adenoid ameloblastoma: Conservative approach in a rare odontogenic lesion.
Article in Oral and maxillofacial surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAdenoid ameloblastoma (AA) is a newly recognized, rare odontogenic tumor variant, distinguished by histopathological features that combine characteristics of both ameloblastoma and adenomatoid odontogenic tumor. CASE REPORT: A 32-year-old female with an unilocular radiolucent lesion in the mandible associated with the impacted third molar, diagnosed as AA. Surgical management included complete lesion excision and cryotherapy. Despite the absence of significant symptoms, clinical surveillance is essential, as AA may have high recurrence rates. The recent inclusion of this entity in the WHO Head and Neck Tumor Classification (2022) highlights the need for accurate diagnosis and appropriate interventions to optimize patient prognosis.
conclusionThis report not only contributes to the growing understanding of this tumor biological behavior but also highlights the clinical relevance of documenting such cases to guide best practices and improve prognostic insights in rare odontogenic lesions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.